COVID-19 vaccination and diabetic ketoacidosis  

作　　者：Beuy Joob Viroj Wiwanitkit 

机构地区：[1]Academic Center,Sanitation1 Medical Academic Center,Bangkok 1033300,Thailand [2]Community Medicine,DY Patil Vidhyapeeth,Pune 233230,India

出　　处：《World Journal of Diabetes》2023年第5期560-564,共5页世界糖尿病杂志（英文版）（电子版）

摘　　要：An efficient coronavirus disease 2019(COVID-19)vaccine is urgently required to fight the pandemic due to its high transmission rate and quick dissemination.There have been numerous reports on the side effects of the COVID-19 immunization,with a focus on its negative effects.Clinical endocrinology is extremely interested in the endocrine issue that arises after receiving the COVID-19 vaccine.As was already mentioned,after receiving the COVID-19 vaccine,many clinical problems could occur.Additionally,there are some compelling reports on diabetes.After receiving the COVID-19 vaccine,a patient experienced hyperosmolar hyperglycemia state,a case of newly-onset type 2 diabetes.There has also been information on a potential connection between the COVID-19 vaccine and diabetic ketoacidosis.Common symptoms include thirst,polydipsia,polyuria,palpitations,a lack of appetite,and weariness.In extremely rare clinical circumstances,a COVID-19 vaccine recipient may develop diabetes complications such as hyperglycemia and ketoacidosis.In these circumstances,routine clinical care has a successful track record.It is advised to give vaccine recipients who are vulnerable to problems,such as those with type 1 diabetes as an underlying illness,extra attention.

关 键 词：DIABETES COVID-19 VACCINE KETOACIDOSIS EFFECT 

分 类 号：R587.2[医药卫生—内分泌] R563.1[医药卫生—内科学] R186[医药卫生—临床医学]